Showing results (201-210 of 214) with videos related to
Sort By:
Pageof 22
Journal of Medicinal Chemistry|November 7, 2000
Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanineR J Griffin, C E Arris, C Bleasdale, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor typesJ Baselga, D Rischin, M Ranson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2011
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancerG Rustin, N Reed, G C Jayson, et al.British Journal of Cancer|August 31, 2013
Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanomaR Plummer, P Lorigan, E Brown, et al.Cancer Chemotherapy and Pharmacology|January 1, 1982
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IIA H Calvert, S J Harland, D R Newell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
A phase I and pharmacokinetic study of LY231514, the multitargeted antifolateA C McDonald, P A Vasey, L Adams, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studiesChristopher R Calabrese, Michael A Batey, Huw D Thomas, et al.Investigational New Drugs|January 1, 1996
A phase I clinical study of the antipurine antifolate lometrexol (DDATHF) given with oral folic acidS Laohavinij, S R Wedge, M J Lind, et al.British Journal of Cancer|November 20, 1998
O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanomaM R Middleton, J M Lunn, C Morris, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I study of pharmacologically based dosing of carboplatin with filgrastim support in women with epithelial ovarian cancerM J Lind, S Ghazal-Aswad, L Gumbrell, et al.Pageof 22